» Articles » PMID: 12571850

Synergistic Induction of Nitric Oxide Synthase Type II: in Vitro Effect of Leptin and Interferon-gamma in Human Chondrocytes and ATDC5 Chondrogenic Cells

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 2003 Feb 7
PMID 12571850
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study, in vitro, the effect of leptin (OB), alone or in combination with interferon-gamma (IFNgamma), on inducible nitric oxide synthase (iNOS) and NO production in human primary chondrocytes and in mouse embryonic chondrogenic ATDC5 cells.

Methods: Leptin receptor expression and iNOS messenger RNA expression were evaluated by reverse transcriptase-polymerase chain reaction. Then, iNOS activity was indirectly studied by measuring nitrite accumulation, using the Griess colorimetric reaction, in culture medium of human primary chondrocytes and ATDC5 cells.

Results: ATDC5 mouse embryonic cells expressed functional OB receptor. Alone, neither OB nor IFNgamma produced nitrite accumulation in culture medium. However, costimulation with OB and IFNgamma resulted in dose-dependent up-regulation of the expression of iNOS and NO production in human primary chondrocytes and ATDC5 cells. Production of NO was blunted by the iNOS-specific inhibitors L-N(G)-nitroarginine methyl ester and aminoguanidine. In addition, the janus-activated kinase 2 (JAK2)-specific inhibitor Tyrphostin AG 490 completely blocked OB + IFNgamma-driven up-regulation of iNOS and NO production.

Conclusion: Our data show for the first time a putative proinflammatory role of OB via iNOS induction and NO production. This occurs via activation of JAK2.

Citing Articles

Risk factors associated with degenerative glenohumeral osteoarthritis.

Prakash R, Pathak R, Chen Z, Tai D, BezanPetric U, Rapp E BMJ Open Sport Exerc Med. 2025; 11(1):e002247.

PMID: 39926023 PMC: 11804196. DOI: 10.1136/bmjsem-2024-002247.


Novel perspectives on leptin in osteoarthritis: Focus on aging.

Liu Z, Xie W, Li H, Liu X, Lu Y, Lu B Genes Dis. 2024; 11(6):101159.

PMID: 39229323 PMC: 11369483. DOI: 10.1016/j.gendis.2023.101159.


Progress and Challenges of Topical Delivery Technologies Meditated Drug Therapy for Osteoarthritis.

Shentu C, Wang H, Peng X, Xu D, Qian L, Chen Y Int J Nanomedicine. 2024; 19:8337-8352.

PMID: 39161359 PMC: 11330747. DOI: 10.2147/IJN.S466437.


Characterization of clinical data for patient stratification in moderate osteoarthritis with support vector machines, regulatory network models, and verification against osteoarthritis Initiative data.

Segarra-Queralt M, Galofre M, Tio L, Monfort J, Monllau J, Piella G Sci Rep. 2024; 14(1):11797.

PMID: 38782951 PMC: 11116450. DOI: 10.1038/s41598-024-62212-x.


Effects of Leptin and Body Weight on Inflammation and Knee Osteoarthritis Phenotypes in Female Rats.

Fu Y, Batushansky A, Kinter M, Huebner J, Kraus V, Griffin T JBMR Plus. 2023; 7(7):e10754.

PMID: 37457883 PMC: 10339097. DOI: 10.1002/jbm4.10754.